Anzeige
Mehr »
Login
Mittwoch, 25.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40DLB | ISIN: US81256L2034 | Ticker-Symbol:
NASDAQ
24.12.24
18:40 Uhr
2,030 US-Dollar
+0,040
+2,01 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEASTAR MEDICAL HOLDING CORPORATION Chart 1 Jahr
5-Tage-Chart
SEASTAR MEDICAL HOLDING CORPORATION 5-Tage-Chart

Aktuelle News zur SEASTAR MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSeaStar Medical Holding Corporation: SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial1
DoSeaStar Medical Holding Corp - 8-K, Current Report-
SEASTAR MEDICAL Aktie jetzt für 0€ handeln
11.12.SeaStar Medical Holding Corporation: SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications7
03.12.SeaStar Medical Holding Corporation: SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial1
26.11.SeaStar Medical Holding Corp - 8-K, Current Report-
26.11.SeaStar Medical Holding Corporation: SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 20242
22.11.SeaStar Medical Holding Corporation: Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares2
19.11.SeaStar Medical Chefmediziner erwirbt Aktien im Wert von 8.457 US-Dollar1
15.11.SeaStar Soars on Latest Tidings1
15.11.SeaStar Medical Holding Corporation: SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer85DENVER, Nov. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
► Artikel lesen
13.11.SeaStar Medical Holding Corporation: SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update130DENVER, Nov. 13, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) ("SeaStar Medical" or the "Company"), a commercial-stage medical device company developing proprietary solutions...
► Artikel lesen
13.11.SeaStar Medical Holding Corp - 10-Q, Quarterly Report-
13.11.SeaStar Medical Holding Corp - 8-K, Current Report-
06.11.FDA grants breakthrough status to SeaStar Medical's SCD1
06.11.SeaStar Medical Holding Corporation: FDA Grants Breakthrough Device Designation for SeaStar Medical's Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis220This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage...
► Artikel lesen
01.11.SeaStar Medical Holding Corporation: Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial84DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
► Artikel lesen
31.10.SeaStar Medical Holding Corporation: SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE2
25.10.SeaStar Medical Holding Corporation: Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update1
25.10.SeaStar Medical Holding Corporation: Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 20241
23.10.Nuwellis ends SeaStar distribution and supply agreements2
Seite:  Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1